Aisling Capital Management as of Dec. 31, 2025
Portfolio Holdings for Aisling Capital Management
Aisling Capital Management holds 13 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bridgebio Pharma (BBIO) | 81.3 | $389M | 5.1M | 76.49 | |
| Syndax Pharmaceuticals (SNDX) | 5.8 | $28M | 1.3M | 21.01 | |
| Monte Rosa Therapeutics (GLUE) | 4.8 | $23M | 1.5M | 15.68 | |
| Bicara Therapeutics (BCAX) | 2.0 | $9.6M | 569k | 16.83 | |
| Compass Pathways Sponsored Ads (CMPS) | 1.7 | $8.3M | 1.2M | 6.90 | |
| BridgeBio Oncology Therapeutics Com New (BBOT) | 1.5 | $7.1M | 565k | 12.52 | |
| CalciMedica Com New (CALC) | 0.7 | $3.4M | 521k | 6.59 | |
| Scholar Rock Hldg Corp (SRRK) | 0.7 | $3.4M | 77k | 44.05 | |
| Biomea Fusion (BMEA) | 0.5 | $2.5M | 2.0M | 1.24 | |
| Urogen Pharma (URGN) | 0.5 | $2.5M | 108k | 23.42 | |
| Aclaris Therapeutics (ACRS) | 0.3 | $1.3M | 435k | 3.01 | |
| Marker Therapeutics Com New (MRKR) | 0.1 | $485k | 325k | 1.49 | |
| OnKure Therapeutics Com Cl A (OKUR) | 0.1 | $257k | 89k | 2.90 |
